92 related articles for article (PubMed ID: 1791535)
1. A random walk method for percutaneous drug absorption pharmacokinetics: application to repeated administration of a therapeutic timolol patch.
Kubota K; Koyama E; Yasuda K
J Pharm Sci; 1991 Aug; 80(8):752-6. PubMed ID: 1791535
[TBL] [Abstract][Full Text] [Related]
2. Finite dose percutaneous drug absorption: theory and its application to in vitro timolol permeation.
Kubota K; Yamada T
J Pharm Sci; 1990 Nov; 79(11):1015-9. PubMed ID: 2292763
[TBL] [Abstract][Full Text] [Related]
3. Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface.
Simon L; Ospina J
Math Biosci; 2013 Jul; 244(1):58-67. PubMed ID: 23624255
[TBL] [Abstract][Full Text] [Related]
4. An analytical solution for percutaneous drug absorption: application and removal of the vehicle.
Simon L; Loney NW
Math Biosci; 2005 Oct; 197(2):119-39. PubMed ID: 16135370
[TBL] [Abstract][Full Text] [Related]
5. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
George K
Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
[TBL] [Abstract][Full Text] [Related]
6. Dual sorption model for the nonlinear percutaneous permeation kinetics of timolol.
Kubota K; Koyama E; Twizell EH
J Pharm Sci; 1993 Dec; 82(12):1205-8. PubMed ID: 8308696
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and beta-blocking effects of transdermal timolol.
Kubota K; Yamada T; Kikuchi K; Koyama E; Ishizaki T
Eur J Clin Pharmacol; 1993; 44(5):493-5. PubMed ID: 8359190
[TBL] [Abstract][Full Text] [Related]
8. Water-activated, pH-controlled patch in transdermal administration of timolol. II. Drug absorption and skin irritation.
Sutinen R; Paronen P; Saano V; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):25-31. PubMed ID: 10913750
[TBL] [Abstract][Full Text] [Related]
9. Transdermal delivery of timolol by electroporation through human skin.
Denet AR; Préat V
J Control Release; 2003 Mar; 88(2):253-62. PubMed ID: 12628332
[TBL] [Abstract][Full Text] [Related]
10. [The bioavailability of transdermal therapeutic system of timolol].
Ji XF; Ping QN; Liu GJ; Yu ST
Yao Xue Xue Bao; 1993; 28(8):609-13. PubMed ID: 8285070
[TBL] [Abstract][Full Text] [Related]
11. Water-activated, pH-controlled patch in transdermal administration of timolol. I. Preclinical tests.
Sutinen R; Paronen P; Urtti A
Eur J Pharm Sci; 2000 Jul; 11(1):19-24. PubMed ID: 10913749
[TBL] [Abstract][Full Text] [Related]
12. A novel differentiation method of vehicle models for topically applied drugs: application to a therapeutic timolol patch.
Kubota K; Yamada T; Ogura A; Ishizaki T
J Pharm Sci; 1990 Feb; 79(2):179-84. PubMed ID: 2324968
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects of transdermal bupranolol and timolol in vivo: comparison of microemulsions and matrix patches as vehicle.
Kemken J; Ziegler A; Müller BW
Methods Find Exp Clin Pharmacol; 1991 Jun; 13(5):361-5. PubMed ID: 1921573
[TBL] [Abstract][Full Text] [Related]
14. [Transdermal properties of timolol and factors affecting its permeability in vitro].
Xu YZ; Xu HN
Yao Xue Xue Bao; 1992; 27(6):467-71. PubMed ID: 1442076
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the iontophoretic and passive transdermal delivery of timolol maleate across human cadaver skin.
Soni S; Dixit VK
Pharmazie; 1994 Jan; 49(1):73-4. PubMed ID: 8140139
[No Abstract] [Full Text] [Related]
16. Transdermal timolol delivery from a Pluronic gel.
Stamatialis DF; Rolevink HH; Koops GH
J Control Release; 2006 Nov; 116(2):e53-5. PubMed ID: 17718968
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics, Efficacy, and Safety of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% in Healthy Volunteers: A Phase I Comparison vs. the Corresponding Preservative-free Monotherapies.
Kaarniranta K; Ikäheimo K; Mannermaa E; Ropo A
Clin Pharmacokinet; 2016 Apr; 55(4):485-94. PubMed ID: 26391697
[TBL] [Abstract][Full Text] [Related]
18. A two-dimensional mathematical model of percutaneous drug absorption.
George K; Kubota K; Twizell EH
Biomed Eng Online; 2004 Jun; 3(1):18. PubMed ID: 15202943
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study.
Morsi NM; Aboelwafa AA; Dawoud MHS
J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602
[TBL] [Abstract][Full Text] [Related]
20. Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.
Vlasses PH; Ribeiro LG; Rotmensch HH; Bondi JV; Loper AE; Hichens M; Dunlay MC; Ferguson RK
J Cardiovasc Pharmacol; 1985; 7(2):245-50. PubMed ID: 2581075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
